Phase 2 Recurrent Pericarditis Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Transition to KPL-387 Monotherapy Dosing & Administration Study
PericarditisHeart DiseasesRecurrent Pericarditis
Kiniksa Pharmaceuticals International, plc80 enrolled23 locationsNCT07288216
Recruiting
Phase 2Phase 3
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
PericarditisRecurrent PericarditisPericarditis Acute
Kiniksa Pharmaceuticals International, plc165 enrolled56 locationsNCT07010159
Recruiting
Phase 2
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
Recurrent Pericarditis
Zomagen Biosciences Ltd.50 enrolled17 locationsNCT06836232